ArticleAnnals of hematology2023

Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era - real-world data from Hungary.

Kata Husi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.